CRMD
NASDAQ · Pharmaceuticals
Cormedix Inc
$5.32
+0.09 (+1.72%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+886.8% upside
Low Target
$41.99
Average Target
$52.50
High Target
$66.46
Current Price
$5.32
Current
$5.32
$5.32
Target
$52.50
$52.50
$41.99
$52.50 avg
$66.46
Scenario Analysis
Bear Case
$41.99
689.3%
Low target
Base Case
$52.50
+886.8%
Avg target
Bull Case
$66.46
+1,149.2%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$13.02
-59.1% from high
52-Week Low
$6.13
+-13.2% from low
Target vs 52W High
$52.50
+303.2% vs high
Next Earnings Report
Nov 11, 2026
2d
until earnings
EPS Est: $-0.11
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals